Transformation of in vitro tools for kinase profiling: keeping an eye over the off-target liabilities

Author： Bi Kun   Lebakken Connie S   Vogel Kurt W  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.6, Iss.7, 2011-07, pp. : 701-712

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An evaluation of the latest in vitro tools for drug metabolism studies

By Costa Ana   Sarmento Bruno   Seabra Vítor  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 1, 2014-01 ,pp. : 103-119

Informa Healthcare

Access to resources Recommend Favorite

Recent development in high-throughput bioanalytical support for in vitro ADMET profiling

By Shou Wilson Z   Zhang Jun  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 3, 2010-03 ,pp. : 321-336

Informa Healthcare

Access to resources Recommend Favorite

Rebinding: or why drugs may act longer in vivo than expected from their in vitro target residence time

By Vauquelin Georges  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 10, 2010-10 ,pp. : 927-941

Informa Healthcare

Access to resources Recommend Favorite

Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters

By Ramboer Eva   Vanhaecke Tamara   Rogiers Vera   Vinken Mathieu  

Drug Metabolism Reviews, Vol. 45, Iss. 2, 2013-05 ,pp. : 196-217

Informa Healthcare

Access to resources Recommend Favorite

Designing in vitro assays for drug discovery: a study with the human MAP3 kinase COT

By Jia Yong   Quinn Christopher M   Talanian Robert V  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 7, 2007-07 ,pp. : 909-915

Informa Healthcare

Access to resources Recommend Favorite